Ellagic acid and its methyl-derivatives inhibit a newly found nitratase activity

We have recently shown that low density lipoprotein (LDL) was able to denitrate albumin‐bound 3‐NO2‐Tyr residues and to concomitantly release NO3− through a Ca2+‐dependent process that has been ascribed to a specific protein structure. A lipophilic food component (γ‐tocopherol), which is easily load...

Full description

Saved in:
Bibliographic Details
Published inFundamental & clinical pharmacology Vol. 24; no. 1; pp. 115 - 119
Main Authors Léger, Claude L., Torres-Rasgado, Enrique, Fouret, Gilles, Lauret, Céline, Carbonneau, Marie-Annette
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.02.2010
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We have recently shown that low density lipoprotein (LDL) was able to denitrate albumin‐bound 3‐NO2‐Tyr residues and to concomitantly release NO3− through a Ca2+‐dependent process that has been ascribed to a specific protein structure. A lipophilic food component (γ‐tocopherol), which is easily loaded into LDL has been found to totally inhibit denitrating activity. We presently found that ellagic acid (EA) and its methylated derivatives, 4,4′O‐methyl‐ and 3,3′O‐methyl‐ellagic acids (MeEA1 and MeEA2, respectively), amphipathic phenolic components of certain fruits and beverages, were also able to inhibit this activity, with a total inhibition for EA and a 60% inhibition for MeEA1 and MeEA2. EA exhibited the highest affinity for protein plasma, whereas a higher affinity of MeEA1 and MeEA2 (with MeEA1 > MeEA2) than EA was found for lipoprotein fractions, suggesting that the inhibition‐driving property is protein affinity. As a result of this nitratase‐inhibition property EA and its natural metabolite MeEA2 may have a beneficial role in special physiopathological conditions.
Bibliography:ark:/67375/WNG-0BC22548-5
istex:D1301EA7435E07E3E2EB516EA9426C96A8FE0AF6
ArticleID:FCP734
Both authors contributed equally to this study.
Present address: Claude L. Léger, INRA, UMR1260 “Nutriments Lipidiques et Prévention des Maladies Métaboliques”, Marseille, F‐13385 France; INSERM, U476, Marseille, F‐13385 France; Univ Aix‐Marseille 1, Univ Aix‐Marseille 2, Faculté de Médecine, IPHM‐IFR 125, Marseille, F‐13385 France.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0767-3981
1472-8206
DOI:10.1111/j.1472-8206.2009.00734.x